About Careers MedBlog Contact us

Trials on Peritoneal Dialysis Do Not Report Findings That are Important to Patients

by Ramya Rachamanti on December 24, 2018 at 10:46 AM
Font : A-A+

Trials on Peritoneal Dialysis Do Not Report Findings That are Important to Patients

Patients on peritoneal dialysis and their caregivers give more importance to outcomes that are not present in the majority of clinical trials of peritoneal dialysis, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society of Nephrology (CJASN).

The findings point to the need to focus the selection of outcomes towards those that are important to patients on peritoneal dialysis and their caregivers to support decisions about their health.


Clinical trials typically assess patients' outcomes based on their responsiveness to an intervention, rather than examining outcomes that are directly meaningful to patients. The increasing recognition of the mismatch between the priorities of patients and investigators has prompted efforts to ensure that patient-centered outcomes are identified and integrated into research.

To identify priorities for outcomes in kidney failure patients on peritoneal dialysis and their caregivers, Karine Manera, MIPH (University of Sydney and The Children's Hospital at Westmead, in Australia) and her colleagues conducted focus groups with 81 patients and 45 caregivers from Australia, the United States, and Hong Kong.

The 10 highest ranked outcomes were peritoneal dialysis infection, mortality, fatigue, flexibility with time, blood pressure, peritoneal dialysis failure, ability to travel, sleep, ability to work, and impact on family. These outcomes could be summarized as focusing on health, maintaining lifestyle, and self-management. Interestingly, mortality was ranked first in Australia, second in Hong Kong, and 15th in the United States.

"Research often only reports outcomes that are chosen by researchers and doctors, but may not report findings that are important to patients or their families. This study helps uncover which outcomes and findings are important for patients and their families to know about, so that research can become more relevant to its end-users and ultimately help patients and their families make informed decisions about their treatment," said Manera.

In an accompanying Patient Voice editorial, Jonathan Haydak of the Georgia Institute of Technology College of Engineering, who is a peritoneal dialysis patient, noted that it is easy for patient concerns to get lost in the sea of medical opinions that surround a topic such as kidney disease.

"This is one of the reasons that I am personally involved with the American Association of Kidney Patients - patients need to take charge of their destiny, band together and aspire to bring about the change they want," he wrote. "While it is perhaps not the norm, something as simple as a conversation about values of different outcomes between patients and nephrologists can make for a more successful experience."

Source: Eurekalert


Recommended Reading

Latest Clinical Trials News

 New Clinical Trial Looks Promising as Prostate Cancer Treatment
What is the new trial treatment for prostate cancer? The addition of enzalutamide to the standard of care improved survival of metastatic prostate cancer patients.
Two Promising Cervical Cancer Molecular Targets Discovered
In women with cervical cancer, whole genome sequencing results revealed new potential targets for drug development.
New Approach Uses Nanoparticles to Repair Lymphatic Vessels
Is there a new way to treat lymphedema? Yes, swelling due to damaged lymphatic vessels can be treated using nanoparticles that can travel through the lymphatic vessels.
 Chronic Traumatic Encephalopathy (CTE) Differs in Early and Late Stage
Early and late Chronic Traumatic Encephalopathy (CTE) disease processes in the post-mortem brains were similar in some ways but dramatically different in others.
 Preventing Scar Tissue After Heart Attack With Hydrogel Therapy
Researchers have developed a new hydrogel biomaterial that adheres to heart tissue to prevent scar tissue formation after a heart attack and its consequences.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close

Trials on Peritoneal Dialysis Do Not Report Findings That are Important to Patients Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests